A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.57 USD -5.38% Market Closed
Market Cap: 416.1m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Aquestive Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
6
0
9
(9)
(3)
(34)
(57)
(61)
(80)
(64)
(68)
(66)
(68)
(50)
(48)
(56)
(54)
(64)
(62)
(71)
(69)
(73)
(71)
(54)
(33)
(23)
(12)
(8)
(29)
(26)
Depreciation & Amortization
(0)
1
1
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
1
1
1
1
Stock-Based Compensation
0
0
0
0
0
27
29
30
31
6
7
7
7
7
7
7
6
6
7
7
6
7
5
4
4
2
2
3
4
0
Other Non-Cash Items
1
1
2
3
2
31
37
37
40
12
14
14
14
14
9
11
15
19
23
36
33
31
27
10
8
4
2
5
10
13
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
1
2
4
6
6
6
6
6
6
6
7
7
9
9
9
8
8
7
7
6
6
5
3
6
6
8
8
5
4
4
Change in Working Capital
3
1
7
8
0
9
(0)
8
6
(0)
(1)
(11)
(5)
(16)
(7)
(4)
(10)
4
(3)
(2)
(0)
1
15
32
37
29
16
(5)
(8)
(13)
Cash from Operating Activities
10
N/A
3
-66%
19
+482%
6
-69%
3
-54%
10
+252%
(18)
N/A
(13)
+26%
(31)
-142%
(49)
-56%
(52)
-7%
(60)
-15%
(56)
+7%
(49)
+13%
(43)
+13%
(45)
-7%
(46)
-1%
(38)
+18%
(38)
-2%
(33)
+14%
(33)
-1%
(38)
-14%
(26)
+31%
(10)
+63%
14
N/A
12
-10%
7
-42%
(6)
N/A
(26)
-301%
(25)
+4%
Investing Cash Flow
Capital Expenditures
1
0
(0)
(2)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(0)
(0)
(0)
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(2)
(3)
(1)
(1)
(1)
(0)
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
1
N/A
0
-71%
(0)
N/A
(2)
-3 350%
(2)
+19%
(1)
+16%
(1)
-1%
(2)
-28%
(2)
-7%
(1)
+27%
(1)
+25%
(1)
+38%
(0)
+38%
(0)
N/A
(0)
+12%
(1)
-44%
(0)
+6%
(1)
-18%
(1)
-7%
(1)
-47%
(1)
N/A
(1)
-53%
(3)
-118%
(3)
+17%
(2)
+4%
(3)
-6%
(1)
+61%
(1)
+1%
(1)
-3%
(0)
+78%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
69
69
0
69
0
39
0
39
39
6
16
25
31
30
22
24
18
14
13
10
15
17
99
93
Net Issuance of Debt
5
5
5
5
0
0
0
0
0
(1)
17
17
0
18
0
25
0
0
0
0
0
(1)
(1)
(2)
(12)
(15)
(14)
(22)
(12)
(9)
Other
0
0
0
(1)
(2)
(8)
(11)
(11)
(12)
(6)
(7)
(7)
(4)
(4)
(0)
(3)
(3)
(3)
(3)
(0)
0
(0)
0
0
(0)
(0)
(0)
9
8
8
Cash from Financing Activities
5
N/A
5
N/A
5
-1%
4
-10%
(2)
N/A
(8)
-282%
58
N/A
58
+1%
57
-2%
62
+9%
10
-83%
50
+375%
52
+5%
53
+1%
39
-26%
28
-27%
38
+35%
47
+23%
53
+13%
30
-43%
22
-29%
23
+7%
17
-27%
12
-31%
1
-91%
(5)
N/A
0
N/A
4
+1 428%
95
+2 289%
92
-3%
Change in Cash
Net Change in Cash
16
N/A
9
-46%
24
+177%
8
-66%
(1)
N/A
0
N/A
39
+11 235%
43
+12%
23
-46%
12
-51%
(43)
N/A
(11)
+74%
(4)
+61%
3
N/A
(4)
N/A
(18)
-356%
(8)
+54%
9
N/A
14
+60%
(4)
N/A
(13)
-237%
(17)
-30%
(13)
+24%
(1)
+94%
12
N/A
5
-61%
6
+33%
(3)
N/A
68
N/A
67
-1%
Free Cash Flow
Free Cash Flow
11
N/A
4
-67%
19
+421%
4
-80%
1
-73%
8
+686%
(19)
N/A
(15)
+22%
(33)
-126%
(51)
-51%
(54)
-6%
(61)
-14%
(57)
+7%
(49)
+13%
(43)
+13%
(46)
-7%
(46)
-1%
(38)
+18%
(39)
-2%
(34)
+13%
(34)
-1%
(40)
-15%
(29)
+26%
(12)
+58%
11
N/A
10
-14%
6
-37%
(7)
N/A
(27)
-261%
(25)
+6%

See Also

Discover More